Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
 
Program Contents
bullet Programs
Contact Info

English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760

International Travel
Phone: 1-887-394-8747
Contact CDC-INFO

Keep your kids healthy. cdc.gov/parents
 

Urinary Tract Infections

Disease Listing | General Information | Technical Information | Additional Information

Clinical Features Ranges from painful urination in uncomplicated urethritis or cystitis to severe systemic illness associated with abdominal or back pain, fever, sepsis and decreased kidney function in some cases of pyelonephritis.
Etiologic Agent Usually caused by Escherichia coli, but other Enterobacteriaceae are also important causes of infection.
Incidence In the United States, urinary track infections (UTIs) account for about 4 million ambulatory-care visits each year, representing about 1% of all outpatient visits.
Sequelae Severe infections associated with sepsis can be fatal.
Transmission Usually through fecal contamination of the urinary tract.
Risk Groups General population, but sexually active women are at highest risk for disease.
Surveillance Surveillance is conducted through the National Ambulatory Care Survey.
Trends Increasing antibiotic resistance among E. coli and other Enterobacteriacae to many commonly used antibiotics; interest in muscosal vaccines for prevention of UTIs in high-risk groups; and judicious use of antibiotics for treatment of infections.
Challenges Identifying methods for prevention of UTIs; evaluating the clinical importance of antimicrobial resistance in persons with both cystitis and acute uncomplicated pyelonephritis; and developing guiding principles for judicious use of antibiotics for persons with suspected UTIs.
Opportunities Mucosal vaccines for prevention of UTIs in high-risk populations. Emergency rooms and clinics for high-risk patients may provide useful settings for research on UTIs. Improved use of antibiotics in treatment of suspected UTIs may reduce antimicrobial resistance.
 
 
Date: October 25, 2005
Content source: National Center for Immunization and Respiratory Diseases: Division of Bacterial Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
English and Spanish: (800) CDC-INFO / (800) 232-4636
TTY: (888) 232-6348 / FAX: (770) 488-4760